TET2 c.398del ;(p.P133Qfs*12)

Variant ID: 4-106155495-TC-T

NM_001127208.2(TET2):c.398del;(p.P133Qfs*12)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia.

Science Translational Medicine
Grey, William W; Rio-Machin, Ana A; Casado, Pedro P; Grönroos, Eva E; Ali, Sara S; Miettinen, Juho J JJ; Bewicke-Copley, Findlay F; Parsons, Alun A; Heckman, Caroline A CA; Swanton, Charles C; Cutillas, Pedro R PR; Gribben, John J; Fitzgibbon, Jude J; Bonnet, Dominique D
Publication Date: 2022-06-22

Variant appearance in text: TET2: 397delC; P133fs
PubMed Link: 35731890
Variant Present in the following documents:
  • EMS146397-supplement-Supplementary_Tables.xlsx, sheet 4
View BVdb publication page



Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.

Cancers
Duployez, Nicolas N; Demonchy, Jordane J; Berthon, Céline C; Goutay, Julien J; Caplan, Morgan M; Moreau, Anne-Sophie AS; Bignon, Anne A; Marceau-Renaut, Alice A; Garrigue, Delphine D; Raczkiewicz, Imelda I; Geffroy, Sandrine S; Bucci, Maxime M; Alidjinou, Kazali K; Demaret, Julie J; Labalette, Myriam M; Brousseau, Thierry T; Dupont, Annabelle A; Rauch, Antoine A; Poissy, Julien J; Susen, Sophie S; Preudhomme, Claude C; Quesnel, Bruno B
Publication Date: 2020-07-21

Variant appearance in text: TET2: 398del; P133QfsX12
PubMed Link: 32708264
Variant Present in the following documents:
  • cancers-12-01992-s001.pdf
View BVdb publication page